How to assess clinical implication of catheter ablation for ventricular tachycardia in patients with structural heart diseases.
作者信息
Matsumoto Sayaka, Kataoka Naoya, Imamura Teruhiko
机构信息
Second Department of Internal Medicine University of Toyama Toyama Japan.
出版信息
J Arrhythm. 2025 Apr 11;41(2):e70064. doi: 10.1002/joa3.70064. eCollection 2025 Apr.
Abstract
摘要
相似文献
1
How to assess clinical implication of catheter ablation for ventricular tachycardia in patients with structural heart diseases.如何评估结构性心脏病患者导管消融治疗室性心动过速的临床意义。
J Arrhythm. 2025 Apr 11;41(2):e70064. doi: 10.1002/joa3.70064. eCollection 2025 Apr.
2
Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease.无结构性心脏病患者室性心动过速的射频导管消融术
Circulation. 1992 May;85(5):1666-74. doi: 10.1161/01.cir.85.5.1666.
3
4
A Prospective, Multicentre Randomised Controlled Trial Comparing Catheter Ablation Versus Antiarrhythmic Drugs in Patients With Structural Heart Disease Related Ventricular Tachycardia: The CAAD-VT Trial Protocol.前瞻性、多中心随机对照试验比较结构性心脏病相关室性心动过速患者导管消融与抗心律失常药物治疗的效果：CAAD-VT 试验方案。
Heart Lung Circ. 2023 Feb;32(2):184-196. doi: 10.1016/j.hlc.2022.09.006. Epub 2023 Jan 2.
5
[Comparative study of results of catheter ablation in ventricular tachycardia of different etiologies].
G Ital Cardiol (Rome). 2006 Nov;7(11):754-60.
6
Catheter ablation of ventricular tachycardia using radiofrequency current.
Herz. 1992 Jun;17(3):171-8.
7
Radiofrequency catheter ablation of left ventricular tachycardia in the normal heart.
Aust N Z J Med. 1996 Jun;26(3):380-5. doi: 10.1111/j.1445-5994.1996.tb01926.x.
8
Effectiveness of a percutaneous left ventricular assist device in preventing acute hemodynamic decompensation during catheter ablation of ventricular tachycardia in advanced heart failure patients: A retrospective single-center analysis.经皮左心室辅助装置在预防晚期心力衰竭患者室性心动过速导管消融过程中急性血液动力学恶化的效果：一项回顾性单中心分析。
J Cardiovasc Electrophysiol. 2019 Dec;30(12):2864-2868. doi: 10.1111/jce.14199. Epub 2019 Oct 2.
9
10
Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease: Indications, Strategies, and Outcomes-Part II.结构性心脏病室性心动过速的导管消融：适应证、策略和结果 - 第二部分。
J Am Coll Cardiol. 2017 Dec 12;70(23):2924-2941. doi: 10.1016/j.jacc.2017.10.030.
本文引用的文献
1
Impact of catheter ablation for ventricular tachycardia on left ventricular ejection fraction in patients with structural heart disease.导管消融治疗结构性心脏病患者室性心动过速对左心室射血分数的影响。
J Arrhythm. 2025 Mar 17;41(2):e70042. doi: 10.1002/joa3.70042. eCollection 2025 Apr.
2
Catheter Ablation for Ventricular Tachycardias: Current Status and Future Perspectives.室性心动过速的导管消融：现状与未来展望
J Clin Med. 2024 Nov 12;13(22):6805. doi: 10.3390/jcm13226805.
3
Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER Trial.HFmrEF 或 HFpEF 患者中β受体阻滞剂的现代应用及意义：DELIVER 试验。
JACC Heart Fail. 2024 Apr;12(4):631-644. doi: 10.1016/j.jchf.2023.09.007. Epub 2023 Sep 27.
4
Outcomes of a PAINESD score-guided multidisciplinary management approach for patients with ventricular tachycardia storm and advanced heart failure: A pilot study.室性心动过速风暴和晚期心力衰竭患者PAINESD评分指导下的多学科管理方法的结果：一项初步研究。
Heart Rhythm. 2023 Jan;20(1):134-139. doi: 10.1016/j.hrthm.2022.08.037. Epub 2022 Sep 6.
5
Simultaneous Endocardial and Epicardial Delineation of 3D Reentrant Ventricular Tachycardia.心内膜和心外膜同时勾画 3D 折返性室性心动过速。
J Am Coll Cardiol. 2020 Mar 3;75(8):884-897. doi: 10.1016/j.jacc.2019.12.044.
Zotero 插件